Skeletal demineralization and fractures caused by fetal magnesium toxicity

Journal of Perinatology

Volumn 26, Issue 6, 2006, Pages 371-374

  Wedig, Kathy E ^a   Kogan, J ^b   Schorry, E K ^b   Whitsett, J A ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Fractures; Magnesium; Osteopenia

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CHLOROTHIAZIDE; DEXAMETHASONE; DIURETIC AGENT; INDOMETACIN; IRON; MAGNESIUM SULFATE; OXYGEN; PHOSPHATE; PHOSPHORUS; SPIRONOLACTONE; SULINDAC; TERBUTALINE; VITAMIN D;

ARTICLE; BONE DEMINERALIZATION; CALCIUM BLOOD LEVEL; CASE REPORT; CHILDBIRTH; DISEASE SEVERITY; FEMALE; FETUS; FRACTURE; FRACTURE HEALING; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MATERNAL TREATMENT; MULTIPLE PREGNANCY; NEONATAL RESPIRATORY DISTRESS SYNDROME; OSTEOPENIA; PHOSPHATE BLOOD LEVEL; PREMATURE LABOR; RESPIRATORY CARE; SUPPLEMENTATION;

ADULT; BONE DEMINERALIZATION, PATHOLOGIC; FATAL OUTCOME; FEMALE; FEMUR; FETUS; FRACTURES, BONE; HUMANS; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MAGNESIUM; MAGNESIUM SULFATE; MALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RIBS; TIBIA; TOCOLYTIC AGENTS; TRIPLETS;

EID: 33744511648     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211508     Document Type: Article

References (14)

1. Lamm CI, Norton KI, Murphy R, Wilkins IA, Rabinowitz JG. Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr 1988; 113: 1078-1082.
2. Wilkins IA, Goldberg JD, Phillips RN, Bacall CJ, Chervenak FA, Berkowitz RL. Long term use of magnesium sulfate as a tocolytic agent. Obstet Gynerol 1986; 67: 38S-40S.
3. Cumming WA, Thomas VJ. Hypermagnesemia: A cause of abnormal metaphyses in the neonate. AJR 1989; 152: 1071-1072.
4. Holcomb WL, Shackelford GD, Petrie RH. Magnesium tocolysis and neonatal bone abnormalities - a controlled study. Obstet Gynecol 1991; 78: 611-614.
5. Santi MD, Henry GW, Douglas GL. Magnesium sulfate treatment of preterm labor as a cause of abnormal bone mineralization. J Pediatr Orthop 1994; 14: 249-253.
6. Malaeb SN, Rassi AI, Haddad MC, Seoud MA, Yunis KA. Bone mineralization in newborns whose mothers received magnesium sulfate for tocolysis of premature labor. Pediatr Radiol 2004; 34: 384-386.
7. Koo W, Hockman E. Physiologic predictors of lumbar spine bone mass in neonates. Pediatr Res 2000; 48: 485-489.
8. Mittendorf R, Pryde PG, Lee KS. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2003; 189(2): 613.
9. Donovan EF, Tsang RC, Steichen JJ, Strub RJ, Chen I, Chen MI. Neonatal hypermagnesemia: Effect on parathyroid hormone and calcium homeostasis. J Pediatr 1980; 96: 305-310.
10. Rantonen T, Kaapa P, Jalonen J, Ekblad U, Peltola O, Valimaki I et al. Antenatal magnesium sulphate exposure is associated with prolonged PTH suppression in preterm neonates. Acta Paediatr 2001; 90: 278-281.
11. Matsuda Y, Meeda Y. Effiect of magnesium sulfate treatment on neonatal bone abnormalities. Gynecol Obstet Invest 1997; 44(2): 82-88.
12. Koo W, Tsang R. Calcium Magnesium, Phospborus and Vitamin D in Nutritional Needs of the Preterm Infant. Williams & Wilkins: Baltimore, MD, 1993; P149.
13. Tsukahara H, Kobata R, Tamura S, Mayumi M. Neonatal bone abnormalities attributable to maternal administration of magnesium sulfate. Pediatr Radiol 2004; 34(8): 673-674.
14. Moyer-Mileur LJ, Brunstetter V, McNaught TP, Gill G, Chan GM. Daily physical activity program increases bone mineralization and growth in preterm very low birth weight infants. Pediatrics 2000; 106: 1088-1092.